RecruitingNot ApplicableNCT05452226

Neuromuscular Electrical Stimulation in COPD/Community Acquired Pneumonia

Neuromuscular Electrical Stimulation (NMES) in Patients Hospitalized With Acute Exacerbation of COPD and/or Community Acquired Pneumonia


Sponsor

University of Vermont

Enrollment

8 participants

Start Date

Jul 12, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

In older adults hospitalized for acute medical conditions, immobility, clinical treatments, and the illness itself contribute to physical deconditioning and delirium, hospital-acquired impairments that increase risk for long-term physical and mental disability, other morbidities, and death. In patients with acute respiratory failure, hospital-acquired functional impairments persist long after hospitalization, due to limited use to rehabilitative interventions in the inpatient or post-acute settings. Exercise and early mobilization interventions are safe and improve physical and cognitive impairments, but there are critical barriers to their widespread implementation in acute care and home settings, including mobility limitations, reduced cardiopulmonary reserve, limited staff, and costs. Thus, there is an unmet need to develop interventions that can be utilized in both the inpatient and home environments to improve functional recovery in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and community-acquired pneumonia (CAP). This study addresses this clinical need and these barriers and will provide important feasibility and acceptability data regarding the utility of neuromuscular electrical stimulation (NMES) administered to lower extremity musculature across inpatient and post-discharge settings to improve functional and cognitive recovery in older adults hospitalized for AECOPD/CAP. Initial NMES sessions will begin during participants' stay at UVM Medical Center and will continue at home after hospital discharge. Study participants will be issued a portable NMES device to take home and instructed on its use. They will receive guidance and oversight on the use of the NMES device and will be asked to perform NMES treatments 6 days per week for 60 minutes per day for 6 weeks. Data will be collected via activity monitor, participant questionnaires and clinical assessments including strength testing and 6-minute-walk-test.


Eligibility

Min Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This study tests electrical muscle stimulation (sending small electrical impulses through electrodes placed on the skin to make muscles contract) in hospitalized patients with COPD (chronic obstructive pulmonary disease) or community-acquired pneumonia, to see if it can preserve muscle strength and improve recovery during their hospital stay. **You may be eligible if...** - You are hospitalized with a COPD flare-up or community-acquired pneumonia - You are an adult (18 or older) - Your doctor approves physical therapy-type interventions **You may NOT be eligible if...** - You have a pacemaker or implanted cardiac device (electrical stimulation can interfere) - You have skin conditions or wounds at the electrode placement sites - You are pregnant - Your condition is too unstable to tolerate any stimulation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEneuromuscular electrical stimulation (NMES)

Electrical stimulation will be applied using two adhesive pads affixed to the front of both of the thighs. The intensity will be progressively increased to a level that provokes a strong contraction. The stimulation intensity will be increased until the stimulation is uncomfortable, but does not hurt. Care will be taken to make sure that the level of stimulation will be adjusted such that the intensity does not cause pain. Contractions will last 10 seconds, with 30 seconds of rest between. NMES will occur 6 days per week for 60 minutes per day. Patients will self-administer NMES 6 days per week after discharge for up to 6 weeks.


Locations(1)

University of Vermont

Burlington, Vermont, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05452226


Related Trials